These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16753356)

  • 21. Treatment of Peyronie's disease with local interferon-alpha 2b.
    Brake M; Loertzer H; Horsch R; Keller H
    BJU Int; 2001 May; 87(7):654-7. PubMed ID: 11350406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie's Disease.
    Seftel AD
    J Urol; 2016 May; 195(5):1562-1563. PubMed ID: 27186764
    [No Abstract]   [Full Text] [Related]  

  • 23. Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2B treatment in Peyronie's disease.
    Andresen R; Wegner HE; Banzer D; Miller K
    Acta Radiol; 1996 May; 37(3 Pt 1):352-6. PubMed ID: 8845268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional recombinant interferon alpha-2b in Peyronie's disease.
    Astorga R; Cantero O; Contreras D; del Río-Martín A; Labarta-Beceiro V; Gutiérrez-Elvírez A; Lima-López MA; López-Saura P
    Arch Esp Urol; 2000 Sep; 53(7):665-71. PubMed ID: 11037665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Review of Peyronie's disease].
    Stein A; Dekel Y
    Harefuah; 2012 Nov; 151(11):638-40, 653. PubMed ID: 23367736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman.
    Glina S; Gelbard MK; Akkus E; Jordan GH; Levine LA
    J Sex Med; 2007 Sep; 4(5):1209-13. PubMed ID: 17727345
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium histolyticum collagenase - is this a revolutionary medical treatment for Peyronie's disease?
    Poullis C; Shabbir M; Eardley I; Mulhall J; Minhas S
    BJU Int; 2016 Aug; 118(2):186-9. PubMed ID: 26683137
    [No Abstract]   [Full Text] [Related]  

  • 29. A Primer on the History of Intralesional Verapamil Injection for Peyronie's Disease.
    Levine LA
    Urology; 2023 Mar; 173():5-7. PubMed ID: 36596363
    [No Abstract]   [Full Text] [Related]  

  • 30. [Peyronie's disease: treatment with interferon and laser].
    Candebat Montero LH; Miranda Reyes PL; Díaz García F; González Ferro I; Barbosa Ramos F; Codorniu Furet J
    Arch Esp Urol; 2008 Apr; 61(3):413-23. PubMed ID: 18581679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralesional verapamil for the treatment of Peyronie's disease: a review.
    Levine LA; Estrada CR
    Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic corticosteroid treatment in Peyronie's disease.
    Uzun H
    Med Hypotheses; 2013 Dec; 81(6):1029-30. PubMed ID: 24119766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical and minimally invasive treatments for Peyronie's disease.
    Kumar R; Nehra A
    Curr Opin Urol; 2009 Nov; 19(6):589-94. PubMed ID: 19741538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic advances in the treatment of Peyronie's disease.
    Yafi FA; Pinsky MR; Sangkum P; Hellstrom WJ
    Andrology; 2015 Jul; 3(4):650-60. PubMed ID: 26097120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease.
    Russell S; Steers W; McVary KT
    Eur Urol; 2007 Mar; 51(3):640-7. PubMed ID: 17092631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of intralesional interferon-α2B for the treatment of Peyronie disease.
    Trost LW; Ates E; Powers M; Sikka S; Hellstrom WJ
    J Urol; 2013 Dec; 190(6):2194-9. PubMed ID: 23688848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intralesional collagenase injections in patients with Peyronie's disease: do they IMPRESS and can we afford them?
    Terry T
    BJU Int; 2015 Oct; 116(4):503-4. PubMed ID: 26350578
    [No Abstract]   [Full Text] [Related]  

  • 38. Minimally invasive treatment of Peyronie's disease: evidence-based progress.
    Jordan GH; Carson CC; Lipshultz LI
    BJU Int; 2014 Jul; 114(1):16-24. PubMed ID: 24447536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
    Carson CC; Sadeghi-Nejad H; Tursi JP; Smith TM; Kaufman GJ; Gilbert K; Honig SC
    BJU Int; 2015 Nov; 116(5):815-22. PubMed ID: 25818264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Peyronie's disease with intralesional verapamil injection.
    Levine LA
    J Urol; 1997 Oct; 158(4):1395-9. PubMed ID: 9302129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.